Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 12-2015 | |
| Operating Expenses | 12,132 | 9,053 | 0 | 7,234 | 0 |
| Operating Income | -12,132 | -9,053 | N/A | -7,234 | N/A |
| Other Income | 6 | 2 | 0 | 24 | 0 |
| Pre-tax Income | -12,126 | -9,051 | 0 | -7,211 | 0 |
| Net Income Continuous | -12,126 | -9,051 | N/A | -7,211 | N/A |
| Net Income | $-12,126 | $-9,051 | $N/A | $-7,211 | $N/A |
| EPS Basic Total Ops | -1.44 | -1.07 | N/A | -0.86 | N/A |
| EPS Basic Continuous Ops | -1.44 | -1.07 | N/A | -0.86 | N/A |
| EPS Diluted Total Ops | -1.44 | -1.07 | N/A | -0.86 | N/A |
| EPS Diluted Continuous Ops | -1.44 | -1.07 | N/A | -0.86 | N/A |
| EBITDA(a) | $-12,132 | $-9,053 | $N/A | $-7,234 | $N/A |